Generated by AI
eXoZymes Inc. is a biotechnology company focused on cell-free biomanufacturing platforms that use AI-enhanced enzymes to produce complex molecules outside living cells. The company’s technology is designed to convert affordable feedstocks into high-purity chemicals that are difficult, costly, or inefficient to make through conventional methods. Its current work centers on developing enzyme modules and biocatalytic systems for applications in pharmaceuticals, nutraceuticals, biofuels, and specialty chemicals. By combining synthetic biology, enzyme engineering, and bioreactor-based production, eXoZymes serves markets that require scalable, precise, and adaptable manufacturing solutions. Headquartered in Monrovia, California, eXoZymes positions itself at the intersection of biotechnology and industrial chemistry, supporting the production of valuable molecules used across health, energy, and materials sectors.
Website750 Royal Oaks Drive
Monrovia, CA, 91016
United States
The latest articles about EXOZ.
Summary of Aug 10's posts. Generated by AI.
No summary yet.
No summary yet.
No summary yet.
Summary of Aug 10's posts. Generated by AI.
Investors talking about EXOZ also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.